knowledge -WSS

knowledge

author：explore 2025-10-01 10:36:45 - browse：6844

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Why scientists need input from humanists on sensitive research

hotspot

WSS

Steward Health Care Massachusetts hospitals face fiscal disaster

ARCH Venture Partners is raising $3 billion for a life sciences fund

Commercial surrogacy can be ethical, despite pope’s claims

Even great ERs can’t make up for American health disparities

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Commercial surrogacy can be ethical, despite pope’s claims

knowledge

knowledge

entertainment

Trump demands the U.S. pay no more for drugs than other countries … again

Steward Health Care Massachusetts hospitals face fiscal disaster

Peter Hotez and the public health issue of online harassment

Commercial surrogacy can be ethical, despite pope’s claims

Novavax promises a turnaround & Lilly roils the obesity market

Readout Newsletter: Bristol, Sangamo, Gilead, and more

In age of alternative facts, a scholarly course on calling out crap

UCLA team creates talking throat patch for voice disorders

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

How many hemophilia patients actually want gene therapy?

explore

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

SAMSHA loosens regulations on methadone treatment centers

Male and female sex labels in research insufficient, scientists say

Even great ERs can’t make up for American health disparities

explore

hotspot

hotspot

hotspot